Philip J Batterham, Louise Birrell, Aliza Werner-Seidler, Maree Teesson, Pim Cuijpers, Tracy R G Gladstone, Andrew J Mackinnon, Aimy Slade, Helen Christensen
{"title":"Future directions in depression prevention.","authors":"Philip J Batterham, Louise Birrell, Aliza Werner-Seidler, Maree Teesson, Pim Cuijpers, Tracy R G Gladstone, Andrew J Mackinnon, Aimy Slade, Helen Christensen","doi":"10.1037/ccp0000936","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Rising rates of mental illness in young people over recent decades are a trend that represents a wake-up call across the globe. The causes of this increase are not known. We also know little about effective interventions or implementation strategies to prevent depression in either youth or adults. The need for the prevention of mental ill health represents an outstanding research opportunity for our field.</p><p><strong>Method: </strong>This conceptual article identifies current challenges in our field, provides potential solutions, and suggests the most promising avenues for future solutions and how we might investigate them.</p><p><strong>Results: </strong>Key challenges include the following: poor implementation with low fidelity; methodological challenges related to appropriate sampling, time frames, interventions, and active controls; and lack of fit between interventions and their context. Potential solutions include the following: supplementing trials with evidence from large-scale epidemiological studies, establishing prevention models that work at scale including those that address social determinants and show effectiveness in low- and middle-income countries, building capacity in methods, and strengthening geographically dispersed networks of prevention researchers and practitioners.</p><p><strong>Conclusions: </strong>There are major challenges in conducting prevention research and demonstrating effects. New perspectives and collaborations are needed to overcome existing barriers. (PsycInfo Database Record (c) 2025 APA, all rights reserved).</p>","PeriodicalId":15447,"journal":{"name":"Journal of consulting and clinical psychology","volume":" ","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of consulting and clinical psychology","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1037/ccp0000936","RegionNum":1,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Rising rates of mental illness in young people over recent decades are a trend that represents a wake-up call across the globe. The causes of this increase are not known. We also know little about effective interventions or implementation strategies to prevent depression in either youth or adults. The need for the prevention of mental ill health represents an outstanding research opportunity for our field.
Method: This conceptual article identifies current challenges in our field, provides potential solutions, and suggests the most promising avenues for future solutions and how we might investigate them.
Results: Key challenges include the following: poor implementation with low fidelity; methodological challenges related to appropriate sampling, time frames, interventions, and active controls; and lack of fit between interventions and their context. Potential solutions include the following: supplementing trials with evidence from large-scale epidemiological studies, establishing prevention models that work at scale including those that address social determinants and show effectiveness in low- and middle-income countries, building capacity in methods, and strengthening geographically dispersed networks of prevention researchers and practitioners.
Conclusions: There are major challenges in conducting prevention research and demonstrating effects. New perspectives and collaborations are needed to overcome existing barriers. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
目的:近几十年来,年轻人患精神疾病的比例不断上升,这一趋势值得全球警醒。导致这一增长的原因尚不清楚。我们对预防青少年或成年人抑郁症的有效干预措施或实施策略也知之甚少。预防精神疾病的需求为我们的研究领域提供了一个绝佳的研究机会:这篇概念性文章指出了我们这个领域目前面临的挑战,提供了潜在的解决方案,并提出了未来解决方案中最有希望的途径以及我们可以如何研究这些途径:主要挑战包括:执行不力,保真度低;与适当抽样、时间框架、干预措施和积极控制有关的方法学挑战;干预措施与其背景之间缺乏契合度。潜在的解决方案包括:用大规模流行病学研究的证据对试验进行补充,建立在一定范围内有效的预防模式,包括那些针对社会决定因素并在低收入和中等收入国家显示出有效性的模式,提高方法能力,以及加强地理位置分散的预防研究人员和从业人员网络:在开展预防研究和展示效果方面存在重大挑战。结论:在开展预防研究和展示效果方面存在重大挑战,需要新的视角和合作来克服现有障碍。(PsycInfo Database Record (c) 2025 APA, all rights reserved)。
期刊介绍:
The Journal of Consulting and Clinical Psychology® (JCCP) publishes original contributions on the following topics: the development, validity, and use of techniques of diagnosis and treatment of disordered behaviorstudies of a variety of populations that have clinical interest, including but not limited to medical patients, ethnic minorities, persons with serious mental illness, and community samplesstudies that have a cross-cultural or demographic focus and are of interest for treating behavior disordersstudies of personality and of its assessment and development where these have a clear bearing on problems of clinical dysfunction and treatmentstudies of gender, ethnicity, or sexual orientation that have a clear bearing on diagnosis, assessment, and treatmentstudies of psychosocial aspects of health behaviors. Studies that focus on populations that fall anywhere within the lifespan are considered. JCCP welcomes submissions on treatment and prevention in all areas of clinical and clinical–health psychology and especially on topics that appeal to a broad clinical–scientist and practitioner audience. JCCP encourages the submission of theory–based interventions, studies that investigate mechanisms of change, and studies of the effectiveness of treatments in real-world settings. JCCP recommends that authors of clinical trials pre-register their studies with an appropriate clinical trial registry (e.g., ClinicalTrials.gov, ClinicalTrialsRegister.eu) though both registered and unregistered trials will continue to be considered at this time.